(Finance) – The Board of Directors of Igeameda company of the Igeam Group and leading operator in Italy in the supply of occupational medicine, health promotion and corporate welfare services listed on the Euronext Growth Milan market, resolved to proceed with the
convocation of the assembly ordinary session of the shareholders to resolve on the proposal of withdrawal from trading by Euronext Growth Milan.
The Delisting is justified because, as verified by the Issuer on the basis of the two and a half years since the IPO, the company was unable to adequately value its quotation on EGM Pro and therefore failed to progress in pursuing its growth objectives, both internally and externally. This basically due to the market upheaval that occurred during the COVID period and in the one immediately following it, in which the lack of healthcare professionals had a very important impact on the profitability of Igeamed’s activities as well as the increase in the company’s value operating in the sector and already owning outpatient clinics and clinical laboratories has made any path based on acquisitions uneconomical.